Immunocytochemical localization of cleaved caspase-3 in pancreatic islets from type 1 diabetic subjects

Islets

Volumn 2, Issue 1, 2010, Pages 24-29

  Tomita, Tatsuo ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Caspase 3; Immunocytochemistry; Pancreatic islets; Type 1 diabetes

Indexed keywords

CASPASE 3; CASPASE 3 ANTIBODY; ENZYME ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PANCREAS ISLET; PANCREAS ISLET CELL; ADOLESCENT; ANIMAL; CASE CONTROL STUDY; CELL DEATH; CELL SEPARATION; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROTEIN PROCESSING; RABBIT; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; AGED; ANIMALS; CASE-CONTROL STUDIES; CASPASE 3; CELL DEATH; CELL SEPARATION; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PROTEIN PROCESSING, POST-TRANSLATIONAL; RABBITS; TISSUE DISTRIBUTION;

EID: 85046915669     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.2.1.10041     Document Type: Article

References (19)

1. Martin SJ, Green DR. Protease activation during apoptosis: death by thousand cuts? Cell 1995; 82:349-52.
2. Cohen GM. Caspases: the excursions of apoptosis. Biochem J 1997; 326:1-16.
3. Hirata H, Takahashi A, Kobayashi S, Yonehara S, et al. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fasinduced apoptosis. J Exp Med 1998; 187:587-600.
4. Tewari M, Quan LT, O'Rourke K, Desnoyers S, et al. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 1995; 81:801-9.
5. Gown AM, Willingham MC. Improved detection of apoptotic cells in archival paraffin sections: Immunohistochemistry using antibodies to cleaved caspase 3. J Histochem Cytochem 2002; 50:449-54.
6. Cleaved Caapase-3 (Asp 175) Antibody, Cell Signaling Technology, Publication Cell Signaling Technology, Beverly MA 2006; 9661:1-7.
7. Butler AE, Jansen J, Bonner-Weir S, Ritzel R, et al. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52:102-10.
8. Cnop M, Welsh N, Jonas JC, Jorns A, et al. Mechanisms of pancreatic-β cell death in type 1 and type 2 diabetes. Diabetes 2005; 54:97-107.
9. Tomita T, Iwata K. Gelatinases and inhibitors of gelatinases in pancreatic islets and islet cell tumors. Mod Pathol 1997; 10:47-54.
10. Tomita T. Metallothionein in pancreatic endocrine tumors. Mod Pathol 2000; 13:389-95.
11. Tomita T. Caspase-3 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors. Hum Pathol 2009, 40:1050-2.
12. Milliga CE, Prevette D, Yagimura H, Homma S, et al. Peptide inhibitors of the ICE proteinase family arrest programmed cell death of motorneurons in vivo and in vitro. Neuron 1995; 15:385-93.
13. Enari M, Talanian RV, Wong WW, Nagata S. Sequential activation of ICE-like and CPP32-like proteinases during Fas-mediated apoptosis. Nature 1996; 380:723-6.
14. Yamada K, Ichikawa F, Ishikawa-Shigemoto S, Yuan X, et al. Essential role of caspase-3 in apoptosis of mouse β cells transfected with human Fas. Diabetes 1999; 48:478-83.
15. Marchetti P, DelGuerra S, Marselli L, Lupi R, et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by Metform. J Clin Endocrinol Metab 2004; 89:5535-41.
16. Tomita T. New markers for pancreatic islets and islet cell tumors. Pathol Int 2002; 52:425-32.
17. Tomita T. Amylin in pancreatic islets and pancreatic endocrine neoplasms. Pathol Int 2003; 53:591-5.
18. Birdal-Hansen T, Moore WGI, Bodden MK, Mindsot LJ, et al. Matrix metallopro-teinases - Review. Crit Rev Oral Biol 1993; 4:197-250.
19. Perez SE, Cano DA, Dao-Pick T, Rougier JP, et al. Matrix metalloproteinases 2 and 9 are dispensable for pancreatic islet formation and function in vivo. Diabetes 2005; 54:694-701.